Home Applications 219132 Application 219132
Type NDA
Sponsor INTRABIO Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 AQNEURSA LEVACETYLLEUCINE FOR SUSPENSION;ORAL 1GM/PACKET Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N219132-001 AQNEURSA LEVACETYLLEUCINE 1GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2024-09-24
Orange Book patents# Current patent rows page 1 of 1 · 4 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N219132-001 11400067 2037-04-19 U-4170 2025-04-22 N219132-001 12144792 2037-04-19 U-4603 2026-09-23 N219132-001 12433862 2037-04-19 U-4284 2025-10-22 N219132-001 12433863 2037-04-19 U-4285 2025-10-22
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 3 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N219132-001 I-1000 2029-09-18 N219132-001 NCE 2029-09-24 N219132-001 ODE-498 2031-09-24
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 N219132-001 AQNEURSA 1GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2024-09-24 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N219132-001 AQNEURSA 1GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2024-09-24 c2088c7a36db…2026-09-14 22:38:34 2026-08 N219132-001 AQNEURSA 1GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2024-09-24 84e616aacf4f…2026-08-18 06:07:40 2026-07 N219132-001 AQNEURSA 1GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2024-09-24 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N219132-001 AQNEURSA 1GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2024-09-24 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219132-001 AQNEURSA 1GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2024-09-24 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N219132-001 AQNEURSA 1GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2024-09-24 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N219132-001 AQNEURSA 1GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2024-09-24 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N219132-001 AQNEURSA 1GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2024-09-24 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N219132-001 AQNEURSA 1GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2024-09-24 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N219132-001 AQNEURSA 1GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2024-09-24 2680178bc6a6…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N219132-001 AQNEURSA 1GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2024-09-24 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N219132-001 AQNEURSA 1GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2024-09-24 d06236e962d9…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219132-001 AQNEURSA 1GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2024-09-24 a50c72e98297…
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-11-14 07:37:17 2026-10 N219132-001 11400067 2037-04-19 U-4170 2025-04-22 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N219132-001 12144792 2037-04-19 U-4603 2026-09-23 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N219132-001 12433862 2037-04-19 U-4284 2025-10-22 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N219132-001 12433863 2037-04-19 U-4285 2025-10-22 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N219132-001 11400067 2037-04-19 U-4170 2025-04-22 c2088c7a36db…2026-10-15 13:18:30 2026-09 N219132-001 12144792 2037-04-19 U-4603 2026-09-23 c2088c7a36db…2026-10-15 13:18:30 2026-09 N219132-001 12433862 2037-04-19 U-4284 2025-10-22 c2088c7a36db…2026-10-15 13:18:30 2026-09 N219132-001 12433863 2037-04-19 U-4285 2025-10-22 c2088c7a36db…2026-09-14 22:38:34 2026-08 N219132-001 11400067 2037-04-19 U-4170 2025-04-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 N219132-001 12433862 2037-04-19 U-4284 2025-10-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 N219132-001 12433863 2037-04-19 U-4285 2025-10-22 84e616aacf4f…2026-08-18 06:07:40 2026-07 N219132-001 11400067 2037-04-19 U-4170 2025-04-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N219132-001 12433862 2037-04-19 U-4284 2025-10-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N219132-001 12433863 2037-04-19 U-4285 2025-10-22 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N219132-001 11400067 2037-04-19 U-4170 2025-04-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219132-001 12433862 2037-04-19 U-4284 2025-10-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219132-001 12433863 2037-04-19 U-4285 2025-10-22 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219132-001 11400067 2037-04-19 U-4170 2025-04-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219132-001 12433862 2037-04-19 U-4284 2025-10-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219132-001 12433863 2037-04-19 U-4285 2025-10-22 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N219132-001 11400067 2037-08-11 U-4170 2025-04-22 6a471c1ec25d…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219132-001 11400067 2037-04-19 U-4170 2025-04-22 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219132-001 12433862 2037-04-19 U-4284 2025-10-22 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219132-001 12433863 2037-04-19 U-4285 2025-10-22 a50c72e98297…
Observed Orange Book exclusivity history# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join AQNEURSA LEVACETYLLEUCINE IntraBio Inc 0f248e55-d1bb-13f9-e063-6294a90a05ce 2026-09-17 Warnings, Adverse reactions Exact identifier application applno (NDA): 219132 application number: NDA219132
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents# Document, Submission type, Date table Document Submission type Date 79901 ORIG 2024-10-15 79735 ORIG 2024-09-26 79730 ORIG 2024-09-24